TenX Keane Acquisition Stock Quote TENK - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

12.31

Bid

7.50

Ask

19.79

Volume

12,329

11.16 Day's Range 14.33

9.54 52 Week Range 13.97

Market Cap

81.899M

Previous Close

11.39

Open

12.48

Last Trade

12.19

Last Trade Time

Financial Volume

$ 159,345

VWAP

12.9244

Average Volume (3m)

11,909

Shares Outstanding

6,653,077

Dividend Yield

PE Ratio

33.86

Earnings Per Share (EPS)

0.36

Revenue

Net Profit

2.42M

TenX Keane Acquisition is a newly incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TenX Keane Acquisition is a newly incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sector

Blank Checks

Industry

Blank Checks

Headquarters

Grand Cayman, Cym

Founded

1970

TenX Keane Acquisition is listed in the Blank Checks sector of the NASDAQ with ticker TENK. The last closing price for TenX Keane Acquisition was $11.39. Over the last year, TenX Keane Acquisition shares have traded in a share price range of $ 9.54 to $ 13.97.

TenX Keane Acquisition currently has 6,653,077 shares outstanding. The market capitalization of TenX Keane Acquisition is $75.78 million. TenX Keane Acquisition has a price to earnings ratio (PE ratio) of 33.86.

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates PR Newswire CRANFORD, N.J., July 10, 2024 Multiple catalysts for potentially transformative assets in second half of...

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (Nasdaq: TENKU, TENK, TENKR) (the “Company”), announced today that if the proposal to amend the Company’s Amended and...

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain approximately 90% majority control in publicly listed Citius Oncology, Inc. post transaction...

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

New York, NY, Oct. 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its...

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

New York, NY, July 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its...

TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022

New York, NY, Dec. 06, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (Nasdaq: TENKU), a newly incorporated blank check company, today announced that, commencing on December 8...

TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment Option

New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (NASDAQ:TENKU) (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company...

TenX Keane Acquisition Announces Pricing of $60 Million Initial Public Offering

New York, Oct. 13, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company formed for the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.87	7.6048951049	11.44	13.97	9.54	7080	11.08541158	CS
4	1	8.84173297966	11.31	13.97	9.54	9124	11.38864984	CS
12	1.13	10.1073345259	11.18	13.97	9.54	11909	11.36588244	CS
26	1.35	12.3175182482	10.96	13.97	9.54	18090	11.10668837	CS
52	1.67	15.6954887218	10.64	13.97	9.54	17606	11.007305	CS
156	2.11	20.6862745098	10.2	13.97	9.54	20864	10.67749087	CS
260	2.11	20.6862745098	10.2	13.97	9.54	20864	10.67749087	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VSEEVSee Health Inc	$ 4.20 (72.84%)	45.54M
XCURExicure Inc	$ 0.689 (39.22%)	57.78M
INVZWInnoviz Technologies Ltd	$ 0.29 (38.03%)	2
TBIOTelesis Bio Inc	$ 5.5999 (32.70%)	2.55M
NUKKNukkleus Inc	$ 0.4298 (30.24%)	3.88M
GPAKGamer Pakistan Inc	$ 0.0825 (-50.89%)	5.49M
LGMKLogicMark Inc	$ 0.2801 (-39.12%)	917.59k
XPONExpion360 Inc	$ 0.303 (-34.14%)	461.62k
NUZENuZee Inc	$ 3.76 (-28.92%)	858.99k
XYLOXylo Technology Ltd	$ 1.60 (-27.93%)	165.09k
NVDANVIDIA Corporation	$ 107.27 (-1.78%)	464.35M
INTCIntel Corporation	$ 21.48 (-26.06%)	284.53M
SQQQProShares UltraPro Short QQQ	$ 9.89 (7.27%)	281.17M
AMZNAmazon.com Inc	$ 167.90 (-8.78%)	134.91M
AAPLApple Inc	$ 219.86 (0.69%)	102.74M